Apexigen

Apexigen is a clinical-stage biopharmaceutical company focused on the discovery and development of a new generation of antibody therapies for cancer treatment, with an emphasis on novel immuno-oncology products designed to harness the patient's immune system to combat and eradicate cancer. Apexigen is dedicated to the discovery and development of innovative drugs that enhance tumor-specific immunity. Utilizing its APXiMAB™ platform, Apexigen is able to discover antibodies with unique properties targeting both known and novel immune system targets. These antibodies have demonstrated the potential to become the next generation of cancer therapies as we strive to cure cancer.